OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

Fantastic post. It seems that they are following a similar course to the melanoma trial in the sense that they have great data already but are trying to make the data even better with an expanded population. Remember, as Zoriden pointed out earlier, Cutaneous T-Cell is an ORPHAN designation as well that has no cure and if they are able to put together data that is off the charts, fast-track approval would be next just like Merkel Cell. It seems that ONCS is making a concerted effort to skip Phase 3 in all three trials. Wouldn't that be awesome!!!!